BT-001, an oncolytic Vaccinia virus armed with a Treg-depletion-optimized recombinant human anti- CTLA4 antibody and GM-CSF to target the tumor microenvironmentPoster BT-001 M. Semmrich et al. SITC 2020 Download the poster here Poster Presentation